Literature DB >> 10752576

Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale.

E Cubo1, G T Stebbins, L I Golbe, A Nieves, S Leurgans, C G Goetz, K Kompoliti.   

Abstract

An important criterion in scale validation is the demonstration of a stable factor structure. The Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to assess Parkinson's disease (PD). The reliability and applicability of the motor subscale of the UPDRS (UPDRSm) when applied to patients diagnosed with progressive supranuclear palsy (PSP) is unknown. In a sample of 175 patients with PSP, factor analysis revealed five clinically distinct factors: two independent bradykinesia factors (axial/gait and extremities), one rigidity factor, and two independent tremor factors (rest and action). Two items (posture and rest head tremor) did not reach criteria for factor loadings. There was a high degree of internal consistency. These results suggest that UPDRSm is a reliable and applicable scale for assessing most aspects of PSP function as well as severity measures of five clinical disability domains.

Entities:  

Mesh:

Year:  2000        PMID: 10752576     DOI: 10.1002/1531-8257(200003)15:2<276::aid-mds1010>3.0.co;2-q

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

Review 1.  Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

Authors:  Deborah A Hall; Maria João Forjaz; Lawrence I Golbe; Irene Litvan; Christine Ann M Payan; Christopher G Goetz; Albert F G Leentjens; Pablo Martinez-Martin; Anne Pavy-Le Traon; Cristina Sampaio; Bart Post; Glenn Stebbins; Daniel Weintraub; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2015-05-22

2.  Gaze-shift strategies during functional activity in progressive supranuclear palsy.

Authors:  Richard P Di Fabio; Cris Zampieri; Paul Tuite
Journal:  Exp Brain Res       Date:  2006-11-08       Impact factor: 1.972

3.  Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy.

Authors:  Farwa Ali; Stacy R Loushin; Hugo Botha; Keith A Josephs; Jennifer L Whitwell; Kenton Kaufman
Journal:  J Neurol Sci       Date:  2021-08-25       Impact factor: 4.553

4.  Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.

Authors:  Christine A M Payan; François Viallet; Bernhard G Landwehrmeyer; Anne-Marie Bonnet; Michel Borg; Franck Durif; Lucette Lacomblez; Frédéric Bloch; Marc Verny; Jacques Fermanian; Yves Agid; Albert C Ludolph; Peter N Leigh; Gilbert Bensimon
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

5.  Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy.

Authors:  Michael Gold; Stefan Lorenzl; Alistair J Stewart; Bruce H Morimoto; David R Williams; Illana Gozes
Journal:  Neuropsychiatr Dis Treat       Date:  2012-02-09       Impact factor: 2.570

6.  Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.

Authors:  Pieter M Kroonenberg; Frans J Oort; Glenn T Stebbins; Sue E Leurgans; Esther Cubo; Christopher G Goetz
Journal:  BMC Med Res Methodol       Date:  2006-06-13       Impact factor: 4.615

7.  Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy.

Authors:  Ruwei Ou; Wei Song; Qianqian Wei; Ke Chen; Bei Cao; Yanbing Hou; Bi Zhao; Huifang Shang
Journal:  Parkinsons Dis       Date:  2016-06-05

8.  Assessing bradykinesia in parkinsonian disorders.

Authors:  Gian Pal; Christopher G Goetz
Journal:  Front Neurol       Date:  2013-06-03       Impact factor: 4.003

9.  Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

Authors:  C Guevara; K Bulatova; G J Barker; G Gonzalez; N Crossley; M J Kempton
Journal:  Parkinsons Dis       Date:  2016-04-14

Review 10.  Clinical Approach to Progressive Supranuclear Palsy.

Authors:  Helen Ling
Journal:  J Mov Disord       Date:  2016-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.